Zacks Research Brokers Boost Earnings Estimates for Biogen
Biogen Inc. (NASDAQ:BIIB - Free Report) - Research analysts at Zacks Research increased their Q1 2026 earnings per share estimates for shares of Biogen in a research report issued on Wednesday, October 22nd. Zacks Research analyst Team now anticipates that the biotechnology company will post earning

What's Your Reaction?











